TG THERAPEUTICS, INC. (TGTX) Net margin 2016–2025
TG THERAPEUTICS, INC. (TGTX) net profit margin by fiscal year — reported net income divided by reported revenue.
72.6%FY2025 · since FY2016: -51482.2% → 72.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 72.6% | +65.5 pp |
| FY2024 | 7.1% | +1.7 pp |
| FY2023 | 5.4% | +7125.7 pp |
| FY2022 | -7120.3% | -1916.2 pp |
| FY2021 | -5204.1% | +178599.2 pp |
| FY2020 | -183803.3% | -70072.4 pp |
| FY2019 | -113730.9% | +402.0 pp |
| FY2018 | -114132.9% | -36188.2 pp |
| FY2017 | -77944.7% | -26462.5 pp |
| FY2016 | -51482.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice